The Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels
NCT ID: NCT01765010
Last Updated: 2013-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
88 participants
INTERVENTIONAL
2013-01-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Sunlight Exposure and Vitamin D Supplementation on Serum 25-hydroxyvitamin D Levels
NCT03310242
Vitamin D Supplementation and Metabolism in Vitamin D Deficient Elderly
NCT01145703
Treatment of Vitamin D Insufficiency
NCT00933244
Vitamin D Deficiency Epidemiological Research in Sichuan, China
NCT01457365
The Impact of Severe Vitamin D Deficiency and Its Correction on Bone Mineral Density (BMD) in Postmenopausal Women
NCT01694355
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo control
Placebo control
Placebo
Cholecalciferol 1000IU
Cholecalciferol 1000IU qd for 8 weeks
Cholecalciferol
alfacalcidol
alfacalcidol 0.5ug qd for 8 weeks
Alfacalcidol
Calcitriol
Calcitriol 0.25ug qd for 8 weeks
Calcitriol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Calcitriol
Alfacalcidol
Cholecalciferol
Placebo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Subjects with kidney or liver diseases
* Subjects with uncorrectable hypercalcemia or hypocalcemia
* Subjects with chronic gastrointestinal disorders or malabsorption
* Subjects taking medication related to bone loss
20 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chan Soo Shin, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Medical School
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNUH-ENDO-2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.